MIDI has just returned from Advanced Therapies Week in Miami

We are proud to be providing advances to the biopharma industry related to CAR T-Cell biotherapy fabrication, resulting in next-generation cancer treatment solutions.

MIDI assists the biopharmaceutical community with the development of advanced instrumentation, disposables, and system architecture to support effective cell therapy development from the lab through to rapid commercialization scale-up while maintaining biologic integrity.

Utilizing our DevelopmentDNA™, agile development process, and deep knowledge of digitalization/automation, workflow is optimized and reliability enhanced. One unique area of focus is in providing a phase shift in how current autologous CAR T-Cell biopharma drugs are fabricated, moving the fabrication process from the few centralized cleanroom facilities available and scaling to many POC (Point of Care) environments thought the country. This approach involves a contiguous, closed system approach, consisting of the complete biopharma drug fabrication process in one instrument/disposable solution, which is simple to use and FDA-approved under an ISO-13485 QMS.

MIDI is proud of its team and the developments underway to make personalized regenerative medicines at scale in POC environments!

Digital Health took the Center Stage at this year’s CES 23:

MIDI attended this year’s CES event in support of client product launches. There were many examples of medical devices embodying consumer-facing technology and design aiming to personalize, improve and support the individual healthcare journey. In addition to the well-attended show, there was a noticeably expanded focus on healthcare technologies that span regulated and non-regulated health monitoring devices such as digital health panels, wearables, AI software, diagnostics, surgical, infection prevention, and smart home healthcare applications, to name a few. Based on the expanded presence of medical devices and digital healthcare at CES, medical manufacturers are taking great interest based on the desire to discover new technologies and strategic applications to better serve the customers and patients they serve, whether at home or in the clinic.

A new Innovation Vault™ White Paper, Point of Care and At-Home Diagnostics: Applications, Key Topics, and Innovation will be coming soon. Stay tuned for your downloadable digital copy taking us on a deep dive of one of healthcare’s largest and most rapidly expanding market segments, point-of-care (POC) and at-home rapid diagnostic testing.